News Industry News Efemoral Medical Announces Successful First-In-Human Use of The Efemoral™ Vascular Scaffold System December 14, 2020
News Conference News VIVA 2020 BVS Reboot? Signs of Durability to 2 Years in Critical Limb-Threatening Ischemia L.A. McKeown November 11, 2020
Presentation TCT 2020 Featured Clinical Research: (TCT36010) MOTIV BTK Pilot Study – Initial Safety and Performance Study of the MOTIV Sirolimus-Eluting Bioresorbable Coronary Scaffold; Initial Report on First 10 Patients Presenter: Michel Bosiers October 15, 2020
Presentation TCT 2020 Natural Vascular Scaffolding for PVD Interventions (Alucent) Presenter: Myles Greenberg October 15, 2020
News Conference News TCT 2020 Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB Michael O'Riordan October 14, 2020
Presentation TCT 2020 TCT 529: 12-y/o Female Patient Treated With a Second-Generation Tyrocore Sirolimus-Eluting Bioresorbable Scaffold in a Denovo Coronary Stenosis in the Donor Heart After Transplantation Presenter: Matthias Lutz October 14, 2020
Presentation TCT 2020 TCT 317: Twelve-Month Clinical Outcomes of Sirolimus-Eluting Bioresorbable Peripheral Scaffold System Following Percutaneous Transluminal Angioplasty of Below-the-Knee Arteries in Patients With Critical Limb Ischaemia: The CREDENCE BtK-1 Study Presenter: Vijay Thakore October 14, 2020
Presentation TCT 2020 TCT 362: Natural Vascular Scaffolding Therapy Shows Favorable Biocompatibility and Protection of Elastin Content in Comparison to Balloon Angioplasty and Stent in Peripheral Arteries of LDLR-Knockout Hypercholesterolemic Swine Presenter: Greg Kaluza October 14, 2020
Presentation TCT 2020 TCT 268: Safety and Performance of the Resorbable Magnesium Scaffold, Magmaris in a Real World Setting – NSTEMI, Diabetes and B2/C Lesion Subgroups Analyses of the First Cohort Subjects at 12-month Follow-up of the BIOSOLVE-IV Registry Presenter: Adrian Wlodarczak October 14, 2020
Presentation TCT 2020 TCT 269: A First-in-Human Study of the Second-Generation, Thin-Strut, Everolimus-Eluting Bioresorbable Scaffold: Final IVUS and OCT Results From the FAST Clinical Trial Presenter: Takeshi Nishi October 14, 2020
Presentation TCT 2020 TCT 273: Sirolimus Eluting, Tyrocore, Bioresorbable Vascular Scaffold Implantation in Patients with ST Segment Elevation Myocardial Infarction: 12 Month Outcomes – FANTOM STEMI Pilot Study Presenter: Lukasz Koltowski October 14, 2020
Presentation TCT 2020 TCT 278: Prevalence and Anatomical Factors Associated to Vascular Remodeling Following Bioresorbable Scaffold Implantation Presenter: Tatsuhiro Fujimura October 14, 2020
Presentation TCT 2020 TCT 275: FANTOM II Long Lesion Study: Initial Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold in Long Lesions – First Report: 1 Year Outcomes Presenter: Matthias Lutz October 14, 2020
News Conference News EuroPCR 2020 DynamX Bioadaptor Provides Promising Preliminary Results for De Novo Coronary Lesions Todd Neale June 30, 2020
News Conference News CRT 2020 Newer, Thinner-Strut Abbott Scaffold Prompts Talk of a BVS Comeback Michael O'Riordan February 28, 2020
News Conference News ISC 2020 Another Neuroprotective Agent Fails in Acute Stroke . . . Or Does It? Todd Neale February 21, 2020
Presentation JIM 2020 Present and future of resorbable magnesium scaffold. An expert review. Presenter: Stefano Galli February 13, 2020
News Conference News LINC 2020 COMPARE: Similar Efficacy and Safety for Paclitaxel Balloons Regardless of Dose L.A. McKeown January 28, 2020